“The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance”, Glob. Scie. Revi., vol. 48, pp. 42–45, Feb. 2026, Accessed: May 06, 2026. [Online]. Available: https://scienticreview.com/index.php/gsr/article/view/602